feed,title,long_url,short_url
SeekingAlpha,AT&T is a blue-chip stock that's posted positive 2022 returns. But is it still a buy?,https://seekingalpha.com/news/3852932,
SeekingAlpha,Hoth Therapeutics granted grace days by Nasdaq to regain compliance with bid price rule,https://seekingalpha.com/news/3852962,
